Home > Healthcare > Pharmaceuticals > Finished Drug Form > Ophthalmology Drugs Market
The rising prevalence of ocular disorders such as glaucoma, cataract, diabetic retinopathy, increasing healthcare expenditure and investments, rising research and development pertaining to the development of novel drugs, increasing focus on developing combination therapies, and increasing advancements in genomics and biomarker research are enabling more personalized approaches to ophthalmic treatments are propelling the market expansion.
As the global population continues to age, the prevalence of age-related eye conditions such as cataracts, age-related macular degeneration (AMD), and glaucoma is rising. The aging population is more susceptible to vision impairment and related eye diseases, leading to an increased demand for ophthalmic treatments.